BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Powell JE, Lim CKW, Krishnan R, McCallister TX, Saporito-Magriña C, Zeballos MA, McPheron GD, Gaj T. Targeted gene silencing in the nervous system with CRISPR-Cas13. Sci Adv 2022;8:eabk2485. [PMID: 35044815 DOI: 10.1126/sciadv.abk2485] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 van der Bent ML, Evers MM, Vallès A. Emerging Therapies for Huntington's Disease - Focus on N-Terminal Huntingtin and Huntingtin Exon 1. Biologics 2022;16:141-60. [PMID: 36213816 DOI: 10.2147/BTT.S270657] [Reference Citation Analysis]
2 Liu L, Pei D. Insights Gained from RNA Editing Targeted by the CRISPR-Cas13 Family. IJMS 2022;23:11400. [DOI: 10.3390/ijms231911400] [Reference Citation Analysis]
3 Bot JF, van der Oost J, Geijsen N. The double life of CRISPR-Cas13. Curr Opin Biotechnol 2022;78:102789. [PMID: 36115160 DOI: 10.1016/j.copbio.2022.102789] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Burris BJD, Molina Vargas AM, Park BJ, O'Connell MR. Optimization of specific RNA knockdown in mammalian cells with CRISPR-Cas13. Methods 2022;206:58-68. [PMID: 35987443 DOI: 10.1016/j.ymeth.2022.08.007] [Reference Citation Analysis]
5 Lim CKW, McCallister TX, Saporito-Magriña C, McPheron GD, Krishnan R, Zeballos C MA, Powell JE, Clark LV, Perez-Pinera P, Gaj T. CRISPR base editing of cis-regulatory elements enables the perturbation of neurodegeneration-linked genes. Mol Ther 2022:S1525-0016(22)00496-8. [PMID: 35965414 DOI: 10.1016/j.ymthe.2022.08.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Tong H, Huang J, Xiao Q, He B, Dong X, Liu Y, Yang X, Han D, Wang Z, Wang X, Ying W, Zhang R, Wei Y, Xu C, Zhou Y, Li Y, Cai M, Wang Q, Xue M, Li G, Fang K, Zhang H, Yang H. High-fidelity Cas13 variants for targeted RNA degradation with minimal collateral effects. Nat Biotechnol 2022. [PMID: 35953673 DOI: 10.1038/s41587-022-01419-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Yang G, Yan Z, Wu X, Zhang M, Xu C, Shi L, Yang H, Fang K. Ptbp1 knockdown failed to induce astrocytes to neurons in vivo.. [DOI: 10.21203/rs.3.rs-1817676/v1] [Reference Citation Analysis]
8 Commission on Novel Technologies for Neurodevelopmental Copy Number Variants. Neurodevelopmental copy-number variants: A roadmap to improving outcomes by uniting patient advocates, researchers, and clinicians for collective impact. Am J Hum Genet 2022;109:1353-65. [PMID: 35931048 DOI: 10.1016/j.ajhg.2022.07.003] [Reference Citation Analysis]
9 Karasev MM, Baloban M, Verkhusha VV, Shcherbakova DM. Nuclear Localization Signals for Optimization of Genetically Encoded Tools in Neurons. Front Cell Dev Biol 2022;10:931237. [DOI: 10.3389/fcell.2022.931237] [Reference Citation Analysis]
10 Segal DJ. The promise of gene editing: so close and yet so perilously far. Front Genome Ed 2022;4. [DOI: 10.3389/fgeed.2022.974798] [Reference Citation Analysis]
11 Lim CK, Mccallister TX, Saporito-magriña C, Mcpheron GD, Krishnan R, Zeballos C MA, Powell JE, Clark LV, Perez-pinera P, Gaj T. CRISPR base editing of cis-regulatory elements enables target gene perturbations.. [DOI: 10.1101/2022.05.26.493649] [Reference Citation Analysis]
12 Li Z, Li Z, Cheng X, Wang X, Ma S, Wang S, Lu Z, Zhang H, Zhao W, Chen Z, Yao Y, Chao L, Li W, Fei T. Intrinsic RNA targeting constrains the utility of CRISPR-Cas13 systems.. [DOI: 10.1101/2022.05.14.491940] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Gupta R, Ghosh A, Chakravarti R, Singh R, Ravichandiran V, Swarnakar S, Ghosh D. Cas13d: A New Molecular Scissor for Transcriptome Engineering. Front Cell Dev Biol 2022;10:866800. [DOI: 10.3389/fcell.2022.866800] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]